Mike Hennessy Jr.

Have cancer-related questions? CURE Educated Patient Summits are a great way to present these questions to experts in the field.

, we remain steadfastly dedicated to providing our readers with answers.

’s Educated Patient Summits, held throughout the year, offer both the chance to hear experts discuss the big issues at the heart of this field and the opportunity to present questions to some of those experts.

One example of the latter can be found in this seasonal issue of 

, as we speak with Dr. Jyoti Malhotra, director of thoracic medical oncology at City of Hope Orange County, in California, and a presenter at the Educated Patient Lung Cancer Summit, to get answers to 10 of the most commonly asked patient questions in the lung cancer space.

You’ll find Malhotra’s insights on treatment options, monitoring and more.

Elsewhere, you will hear from a member of our advisory board — Dr. Michael K. Wong, physician in chief at the Roswell Park Comprehensive Cancer Center in Buffalo, New York — who has some helpful and actionable advice on how patients can get the most out of the online portals used to communicate with their care team.

Additionally, we report on advancements in the field of antibody-drug conjugates and speak with two patients with breast cancer who have benefited from these treatments.

“After two failed clinical trials, I experienced severe despair, but I have gained hope through this new drug,” one patient, 

. “The previous trials had significant side effects … but this new medication has been much easier to tolerate, with only slight appetite loss and fatigue. If there are other patients in a similar situation, I would strongly recommend it.”

For all of the up-to-the-minute oncology updates, be sure to stay tuned to curetoday.com. There, you will find everything from breaking news on the latest FDA approvals to expert context on major cancer news and much more.

Throughout these pages, you’ll find personal stories and expert insights. As always, we hope you find them inspirational and informative. Thank you for reading.

Mike Hennessy Jr.
President and CEO
MJH Life Sciences

For more news on cancer updates, research and education, don’t forget to 

subscribe to CURE®’s newsletters here.

Articles

At CURE, we remain steadfastly dedicated to providing our readers
with answers about cancer research. 

Delivering Answers to Pressing Questions About Cancer

Common Metastatic Breast Cancer Questions Answered by Oncologists

Receiving a cancer diagnosis at any age is a life-altering experience, but for adolescents and young adults (AYAs) already navigating a potentially tumultuous time of life, the challenges can be amplified.

 such as Stacy Leung who, at just 23 years old, received a diagnosis of stage 2 triple-negative breast cancer. She received a second diagnosis of breast cancer 12 years later, as she was preparing for her wedding. Leung said she found empowerment in planning.

“I was at a point where I was working with a wedding event planner, I [already] got my dress and I’m like, ‘OK, this is what’s happening,’” Leung explained. “Having the unknown was the hardest part. Once I had a game plan, it was fine because I knew exactly what the moves were and what was going to happen.”

Leung’s is the latest among countless stories we have had the privilege to report on during the first 25 years of MJH Life Sciences®.

Since we started quarter century ago with a single brand, we have launched thousands of video programs, developed cutting-edge conferences and held thousands of virtual and live events, all while tirelessly covering health care news in print and online.

The driving force behind our evolution remains our passion for improving health care. We are grateful to you, our readers, for joining us on this journey.

Elsewhere in this issue, we take a deep dive into some of the 

latest treatment advancements for small cell lung cancer

, offer insights into how best to prepare for a virtual visit with your physician and feature 

answers to patients’ questions on breast cancer

In this Fall issue of CURE, we focus on AYAs with cancer, latest treatments in small cell lung cancer, preparing for a virtual visit and answering common questions about breast cancer.

Choices About Cancer Treatment During a Tumultuous Time

“It’s not due to a lack of rest — additional rest does not alleviate this fatigue. When people have pervasive fatigue, it could be mental fatigue or physical," Luke Peppone, of the University of Rochester in New York, said about cancer-related fatigue. 

This September, MJH Life Sciences, the parent company of 

, celebrates our 25th anniversary. The innovation in health care over the past 25 years has been nothing short of miraculous! Together, we have witnessed significant advances that have provided new cancer treatments. Throughout these changes and into the future, MJH Life Sciences is committed to providing high-quality information and education.

Cancer-related fatigue is a common side effect most survivors experience after receiving treatment. This kind of fatigue is felt physically, mentally and emotionally, which can significantly affect one’s quality of life. It creates a challenge for all aspects of everyday life, including work, relationships with loved ones and even the completion of daily tasks, such as laundry. Focusing energy on cancer-related fatigue is crucial, and this fall issue of Heal dives into how survivors can help manage that side effect.

“Cancer-related fatigue is a fatigue that is pervasive throughout the body,” says Luke Peppone, of the University of Rochester in New York. “It’s not due to a lack of rest — additional rest does not alleviate this fatigue. When people have pervasive fatigue, it could be mental fatigue or physical.”

We hear two survivors’ stories about how they’ve learned to 

by taking breaks and making the most of energy spurts. Elsewhere in this feature, we speak with a director of cancer rehabilitation who emphasizes the importance of exercising, especially when the fatigue is intense, and the steps to take to start noticing an improvement.

Also in this issue, the side effect of hearing loss from chemotherapy is explored. We speak with a distinguished professor from the University of South Florida about what survivors can do to maintain their hearing and what to avoid.

, a comedian and metastatic breast cancer survivor, discusses her nine-year experience with the disease and how she cultivates a community on social media. Sharing short-form videos on Instagram and TikTok has given her a chance to share the good, the bad and the ugly, which can be “the most healing part.”

 to spice up your cookbook. These dishes are packed with essential vitamins and minerals, providing you with the sustenance your body needs. If you’d like to cozy up on a rainy day, I encourage trying the turmeric ginger latte.

As always, we hope you find our stories inspirational and informative. Thank you for reading.

Cancer-related fatigue is felt physically, mentally and emotionally, which can significantly affect one’s quality of life. 

Powering Through Fatigue After Cancer

In this issue of CURE Summer, we heard from individuals whose faith helped during challenging times. 

From cutting-edge science to deeply personal matters of faith, this latest seasonal issue of 

provides a wide-ranging look at many facets of a cancer journey.

We recognize that cancer can raise profound spiritual and existential questions. This issue explores the relationship between cancer and faith as we hear from individuals who have found solace in their beliefs during challenging times and speak with experts about the impact that cancer can have on a person’s spiritual views.

“There was a study a few years ago, and I think they surveyed over 2,000 people, the majority of whom, 70%, said that their faith had gotten stronger as a result of their cancer diagnosis,” said Dr. John Peteet, a psychiatrist at Brigham and Women’s Hospital and Dana- Faber Cancer Institute in Boston. “Only about 17% said that they experienced a negative effect on their faith.”

We also look at the Food and Drug Administration’s approval of Alecensa (alectinib) for patients with ALK-positive non-small cell lung cancer, which followed the notable results of the phase 3 ALINA trial.

“The ALINA study, in my mind, is a landmark study ... because it shows that using the ALK inhibitor [Alecensa] for early-stage lung cancer after surgery increases the survival rate of patients as compared [with] chemotherapy,” said Upal Basu Roy, executive director of research for the LUNGevity Foundation.

Elsewhere in this issue, we delve into the latest research on cancer vaccines, and discuss the potential impact of these vaccines and how they might revolutionize cancer care in the years to come.

This issue spotlights the winners of the 2024 

poetry contest, which invited patients and survivors of cancer, as well as their caregivers, family and friends, to submit poems related to the disease. More than 100 entries were received, and the four winning poems are presented here.

Additionally, this issue celebrates the honorees of CURE Media Group’s 2024 Extraordinary Healer Award, which honors nurses in the cancer community.

In the 2024 CURE Summer issue, we focused on a facet of cancer: the question of faith. 

Mike Hennessy Jr.

Delivering Answers to Pressing Questions About Cancer

Choices About Cancer Treatment During a Tumultuous Time

Powering Through Fatigue After Cancer

Cancer and the Question of Faith

Latest News